Latin America Crispr And Cas Genes Market Size & Outlook
Latin America crispr and cas genes market, 2018-2030 (US$M)
Related Markets
Latin America crispr and cas genes market highlights
- The Latin America crispr and cas genes market generated a revenue of USD 149.8 million in 2024.
- The market is expected to grow at a CAGR of 14.1% from 2025 to 2030.
- In terms of segment, product was the largest revenue generating product & service in 2024.
- Service is the most lucrative product & service segment registering the fastest growth during the forecast period.
- Country-wise, Brazil is expected to register the highest CAGR from 2025 to 2030.
Latin America data book summary
| Market revenue in 2024 | USD 149.8 million |
| Market revenue in 2030 | USD 323.8 million |
| Growth rate | 14.1% (CAGR from 2025 to 2030) |
| Largest segment | Product |
| Fastest growing segment | Service |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Product, Service |
| Key market players worldwide | AstraZeneca PLC, Caribou Biosciences Inc Ordinary Shares, Cellectis SA, CRISPR Therapeutics AG, Editas Medicine Inc, Roche Holding AG, PerkinElmer, Genscript Biotech Corp Class H, Danaher Corp, Intellia Therapeutics Inc, Lonza Group Ltd, Merck KGaA, Takara Bio Inc, Thermo Fisher Scientific Inc, Cibus Inc Ordinary Shares - Class A, Beam Therapeutics Inc, Vertex Pharmaceuticals Inc, Addgene, EGenesis, Synthego, Mammoth Biosciences, Inscripta, PLANTEDIT, Hera Biotech, Origene Technologies, Recombinetics |
Other key industry trends
- In terms of revenue, Latin America region accounted for 3.2% of the global crispr and cas genes market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 3,185.9 million by 2030.
Product was the largest segment with a revenue share of 87.38% in 2024. Horizon Databook has segmented the Latin America crispr and cas genes market based on product, service covering the revenue growth of each sub-segment from 2018 to 2030.
The region requires high investment to boost innovation and Intellectual Property (IP) developments pertaining to DNA modification. Presence of major gene-based diseases, along with an increased number of training workshops undertaken by scientists and researchers in the region, is expected to increase Latin America’s demand for CRISPR and Cas genes.
Gene therapy is expected to ease the social and financial burden of various medical conditions in the region, thereby boosting the demand for CRISPR technology. Latin America is engaged in the large-scale production of Genetically Modified (GM) crops.
Extensive research pertaining to CRISPR technology and experimenting to make bananas resistant to a strain of deadly fungus, ravaging plantations in Latin America, is expected to pave the way for numerous opportunities.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
CRISPR And Cas Genes Market Scope
CRISPR And Cas Genes Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Latin America crispr and cas genes market size, by country, 2018-2030 (US$M)
Latin America CRISPR And Cas Genes Market Outlook Share, 2024 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
